Mark Rothera is the founder of Silence Therapeutics. Silence Therapeutics has raised $120M in total funding. Latest round: Series B.
Mark Rothera is an industry veteran with 30+ years of biopharma leadership experience. He has a strong reputation for driving the successful scale-up of multiple biotech companies, focusing much of his career on specialty diseases and novel modalities including gene therapy and RNAi therapies.
Full founder directory · Investor directory · Company funding database · Fundraising library